Caixa Impulse 2018 awarded 3 UB-Fund. Bosch i Gimpera projects led by IBUB researchers. The 3 selected projects are:
“First-in-class dimerization inhibitors of the androgen receptor as novel therapeutics against prostate cancer”, by the lecturer Eva Estébanez, from the Faculty of Biology, to identify and verify dimerization inhibitors of the androgen receptor (iARdim) as potential drugs to fight prostate cancer.
The project “Novel compounds for the treatment of neurodegenerative disorders”, led by Carmen Escolano, from the Faculty of Pharmacy and Food Sciences, will allow researchers carry out in vivo studies on candidate compounds for the treatment of neurodegenerative diseases.
“New HRI activators for the treatment of type 2 diabetes mellitus”, presented by Manuel Vázquez, also from the Faculty of Pharmacy and Food Sciences, will define the development strategy and improvement of HRI activators for the treatment of type 2 diabetes mellitus.
The projects have been selected to take part in the program Caixa Impulse 2018, which offers an economic aid of about 50,000 and 100,000 euros to work on a valorisation and commercialization plan for technologies in the field of health and life sciences.
